00:00 / 00:00
Immune system
Anaphylaxis
Asthma
Food allergy
Type I hypersensitivity
Autoimmune hemolytic anemia
Goodpasture syndrome
Graves disease
Hemolytic disease of the newborn
Myasthenia gravis
Pemphigus vulgaris
Rheumatic heart disease
Type II hypersensitivity
Poststreptococcal glomerulonephritis
Serum sickness
Systemic lupus erythematosus
Type III hypersensitivity
Contact dermatitis
Graft-versus-host disease
Type IV hypersensitivity
Asplenia
Common variable immunodeficiency
Hyperimmunoglobulin E syndrome
IgG subclass deficiency
Isolated primary immunoglobulin M deficiency
Selective immunoglobulin A deficiency
X-linked agammaglobulinemia
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Severe combined immunodeficiency
Wiskott-Aldrich syndrome
Complement deficiency
Hereditary angioedema
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
Chediak-Higashi syndrome
Chronic granulomatous disease
Leukocyte adhesion deficiency
Blood transfusion reactions and transplant rejection: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Type II hypersensitivity
0 / 15 complete
0 / 2 complete
of complete
of complete
2022
2021
2020
2019
2018
2017
2016
type II hypersensitivity p. 110
type II hypersensitivity p. 110
type II hypersensitivity reactions p. 110
type II hypersensitivity p. 110
type II hypersensitivity reactions p. 110
in type II hypersensitivity p. 110
type II hypersensitivity p. 110
type II hypersensitivity p. 110
type II hypersensitivity p. 110
blood transfusions p. 112
organ transplants p. 117
rheumatic fever p. 320
Having a hypersensitivity means that the immune system is reacting to something in a way that damages the body rather than protecting it.
There are four different types of hypersensitivities, and the second type or type II hypersensitivity is sometimes called cytotoxic hypersensitivity because a lot of disorders caused by this hypersensitivity involve antibody mediated destruction of healthy cells.
These disorders tend to be tissue specific meaning that the antibodies are generally specific to one type of tissue or organ.
There are other antibody-mediated hypersensitivities that are systemic, and these are generally Type III hypersensitivities.
Our immune system is setup to fight anything that is considered “non-self” right? Anything that’s not “self”, or you.
This works in large part because of a process called central tolerance which is when developing immune cells that are self-reactive get destroyed or inactivated, whereas immune cells that aren’t are allowed to survive.
This happens while they are still in their primary lymphoid organs, which is the thymus for T cells and the bone marrow for B cells.
This process, though, is not perfect and some self-reactive B and T cells will escape.
These escaped self-reactive cells can then attack healthy tissue and result in autoimmune disease.
In type II hypersensitivity these escaped self-reactive B cells become activated and produce IgM or, with the help of CD4 positive T helper cells, IgG antibodies that attach to antigens on host cells.
There are two type of antigens involved with type II hypersensitivity: intrinsic meaning an antigen the host cell normally makes or extrinsic which is an antigen from an infection or even some medications, like penicillin that gets attached to the host cell.
Type II hypersensitivity is a type of immune response in which the immune system attacks the body's own cells or tissues. Type II hypersensitivity is mediated by antibodies, such as IgG and IgM, directed against antigens on host cells, which cause cell and tissue destruction by complement activation or antibody-dependent cell-mediated cytotoxicity. Examples of Type II hypersensitivity reactions include blood transfusion reactions, erythroblastosis fetalis, and autoimmune hemolytic anemia. Treatment options may include avoiding the tigger, and immunosuppressive medications such as systemic glucocorticoids.
Copyright © 2023 Elsevier, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies.
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.